Prelude Therapeutics
PRLD
PRLD
62 hedge funds and large institutions have $119M invested in Prelude Therapeutics in 2022 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 16 increasing their positions, 22 reducing their positions, and 17 closing their positions.
Holders
62
Holders Change
-6
Holders Change %
-8.82%
% of All Funds
1.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
16
Reduced
22
Closed
17
Calls
$2.16M
Puts
–
Net Calls
+$2.16M
Net Calls Change
+$655K
Top Buyers
| 1 |
1
Renaissance Technologies
New York
|
$838K |
| 2 |
2
Two Sigma Advisers
New York
|
$1.23M |
| 3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$4.69M |
| 4 |
4
D.E. Shaw & Co
New York
|
$605K |
| 5 |
CANY
5
Caxton Associates (New York)
New York
|
$438K |
